To support the translation of molecular imaging research into clinical practice

1
Campaign Overview

• To support the translation of molecular imaging
  research into clinical practice
• To foster the use of molecular imaging in drug
  discovery and development
• To engage industry and the molecular
  imaging community
• To raise 5,000,000 over 5 years

2
Value of the Campaign

• Recognizes expanding role of molecular imaging in
  patient care
• Builds on SNMs unique role in medical community
• Highlights importance of molecular imaging in
  drug discovery and development
• Ensures imaging practitioners are well prepared
  to adopt and use this technology
• Ensures medical community is well informed and
  partnerships are formed outside imaging field

3
Goals of the Molecular Imaging Campaign

• Provide indispensable resources for education,
  knowledge exchange, training and networking
• Advocate for molecular imaging and therapy
• Educate and promote collaboration with referring
  physicians and patient groups
• Support innovations in translational research
• Position molecular medicine as an essential tool
  in providing the highest standards of patient
  care around the world

4
Provide indispensable resources for education,
knowledge exchange, training and networking

• Be a central repository for molecular imaging
• Create and award grants and fellowships
• Develop fellowship and residency curriculum
• Conduct workshops to attract and meet diversified
  needs of molecular imaging practitioners
• Implement continuing educational programs and
  web-based training

5
Provide indispensable resources for education,
knowledge exchange, training and networking

• Support clinical trials in nuclear medicine and
  molecular imaging
• Implement communications plan to raise awareness
  that SNM is the indispensable resource for
  molecular imaging

6
Advocate for molecular imaging and therapy

• Proactively lobby for reimbursement and research
  funding
• Strengthen relationships with federal agencies
  and Congress
• Educate community on benefits of molecular
  imaging and emerging technologies

7
Educate and promote collaboration with referring
physicians and patient groups

• Create outreach program for referring physicians,
  patient groups, federal agencies, regulators and
  the general public

8
Support innovations in translational research

• Define translational research from bench to
  bedside research to practice
• Provide institutional grants for training
  workshops on translating basic research into
  clinical application
• Develop research programs to assist new
  investigators in the field of molecular imaging
• Identify new funding opportunities

9
Support innovations in translational research
(contd)

• Develop standardized imaging protocols and
  outcome measures
• Define the role of biomarkers in clinical trials
• Investigate the implications of molecular imaging
  in diagnosis and the prediction and monitoring of
  treatment response
• Develop technology assessment mechanism

10
Support innovations in translational research
(contd)

• Assure the viability of MI through the
  development of techniques that meet a clinical
  need and that are reimbursable
• Partner with basic science organizations,
  academia, and industry to promote translational
  research
• Position SNM as a central repository for
  molecular imaging research
• Identify and validate new tracers

11
SNM will be recognized as the society that
positions molecular medicine as an essential tool
in providing the highest standards of patient
care around the world

• Develop major media marketing plan to influence
  the introduction and acceptance of molecular
  imaging technology and benefits
• Develop an integrated strategic marketing plan to
  position SNM as the recognized leader
• Increase membership by molecular imaging
  professionals outside of nuclear medicine

12
Strategic Plan Implementation

• Molecular Imaging Center of Excellence has the
  lead
• Developed 9 Task Forces and Editorial Board to
  implement objectives/strategies for each goal
• Task Forces include members of the Center, SNM
  Committees and Council, and other leaders in the
  field

13
Overall First Year Accomplishments

• Infrastructure and capacity building
• Rebranding
• New staffing
• Governance (elections, nominating committee)
• Involvement of SNM and wider MI community
• Developed definition for molecular imaging

14
Molecular Imaging Definition

• Molecular imaging is the visualization,
  characterization, and measurement of biological
  processes at the molecular and cellular levels in
  humans and other living systems.
• Molecular imaging typically includes two- or
  three- dimensional imaging as well as
  quantification over time.
• The techniques used include radiotracer
  imaging/nuclear medicine, MRI, MRS, optical
  imaging, ultrasound and others.

15
Communications - Highlights

• Developed new SNM MI community Web site
• Expanded JNM and Newsline coverage
• Created Road Show, Newsletter, email blasts
  with references
• Launched media campaign, rebranding
• Free trial membership

16
Communications Looking Ahead

• MI Supplement
• Begin regular article series in JNMT
• Complete brochures on practical benefits
• Continue and intensify media campaign
• Develop rapid-action unit to respond to timely
  issues through op-eds, etc
• New news services, email blasts and web content

17
Advocacy- Highlights

• Launched first Capitol Hill Day and MI Week
• NCCR Briefing
• Held key Federal agency meetings (CMS, NIH, FDA,
  DOE, OSTP)
• Met with key associations, research organizations
  and companies
• Created outreach database
• Identifying new research funding sources

18
Advocacy- Looking Ahead

• Strengthen strategic partnerships
• ASTRO, ASCO meeting collaboration
• American Chemical Society, American Academy of
  Neurology, NIH Cardiovascular Imaging Symposium
• Conduct educational forums with coalitions and
  patient groups
• Increase outreach to pharmaceutical companies
• Work with NIH Advisory Councils to become
  official liaison

19
Education Highlights

• Expanded MI focus at MWM, Annual Meeting, in JNM
• Molecular Imaging Gateway
• Molecular Imaging Supplement
• New series of articles
• Recommended new clinical/research grants,awards
• Developed curriculum for residents
• Created speakers bureau
• Planning for more workshops, training, Summits

20
Education Looking Ahead

• Have new MI Track at Annual Meeting
• Hold Second Industry/Expert Summit in February
• Develop training workshops and on-line tools
• Outreach to residency program directors
• Make speakers bureau fully operational
• Develop MI scientist curriculum guidelines
• Create scientific roadshow for chapters, others

21
Translational Activities Highlights

• Held action planning retreat for imminently
  emerging technologies in June
• Recommendations from retreat to be published in
  white paper

22
Translational Activities Looking Ahead

• Continuing series of retreats to discuss key
  issues
• New tracer development
• Technology assessment and advancement
• Translational research education
• Standardized imaging protocols
• Protocol and regulatory development
• Ongoing discussions with FDA

23
MI Center of Excellence Leadership

• Martin Pomper, MD., PhD. President
• Henry Van Brocklin, PhD Vice-President
• Carolyn Anderson, PhD Secretary/Treasurer

Staff

• Marybeth Howlett, MEM Staff Director
• Communications/Web Site Editor - TBD
• Zachary Hochstetler Program Manager

24
Task Force Chairs

• Communications Al Sinusas, MD
• Education Carolyn Anderson, Ph.D
• Advocacy Robert Atcher, Ph.D
• Grants Awards Mathew Thakur, Ph.D

25
Task Force Chairs (contd)

• Definitions David Mankoff, MD
• Emerging Technologies Sandy McEwan, MD
• Future Tracers Henry VanBrocklin, PhD
• Membership Scott Holbrook, MS CNMT NCT

26
How to Support the Campaign

• Corporate donations and pledges
• Individual gifts and pledges
• Collaboration in task forces, summits
• Feedback and ideas
• Involvement through MI COE, Web site, list serve

27
Financial Support

• Corporate pledges over five years or less
• Individual gifts and pledges Education and
  Research Foundation
• Donor recognition began in 2006

28
Campaign Leadership and Staff

• Co-chairs of the campaign
• Hadi Moufarrej, GE Healthcare
• Peter S. Conti, M.D., Ph.D. SNM Past President
• Michael D. Devous, Sr., Ph.D. ERF Past
  President
• SNM Campaign staff
• Virginia Pappas CEO
• Theresa Pinkham, Development Director
• Marybeth Howlett Director, MI Center of
  Excellence

29
Industry Donor Categories

• Corporate Circle 500,000 or more
• Corporate Visionary 250,000 - 499,999
• Corporate Partner 100,000 - 249,999
• Corporate Friend 50,000 - 99,999
• Corporate Contributor lt50,000